BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21450719)

  • 21. Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better.
    Balmain S; McDonald MA
    Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1147-53. PubMed ID: 21932957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
    J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction.
    Hai OY; Mentz RJ; Zannad F; Gasparini M; De Ferrari GM; Daubert JC; Holzmeister J; Lam CS; Pochet T; Vincent A; Linde C
    Eur J Heart Fail; 2015 Feb; 17(2):135-43. PubMed ID: 25469668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Magnetic resonance imaging for the evaluation of patients undergoing cardiac resynchronization therapy. Advantages, limitations and perspectives].
    Mele D; Chiodi E; Lombardi M; Bighi S; Feggi L; Milanesi M; Ferrari R
    G Ital Cardiol (Rome); 2010 Nov; 11(11):800-14. PubMed ID: 21348317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
    Mooyaart EA; Marsan NA; van Bommel RJ; Thijssen J; Borleffs CJ; Delgado V; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2011 Jul; 108(1):63-8. PubMed ID: 21529733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Male gender and chronic obstructive pulmonary disease predict a poor clinical response in patients undergoing cardiac resynchronisation therapy.
    Kirubakaran S; Ladwiniec A; Arujuna A; Ginks M; McPhail M; Bostock J; Carr-White G; Rinaldi CA
    Int J Clin Pract; 2011 Mar; 65(3):281-8. PubMed ID: 21314865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of response to cardiac resynchronization therapy--importance of left ventricular dyssynchrony.
    Santos JF; Parreira L; Madeira J; Seixo F; Mendes L; Lopes C; Venâncio J; Lourenço J; Caetano F; Inês L; Mendes M
    Rev Port Cardiol; 2006 Jun; 25(6):569-81. PubMed ID: 17019976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy in paediatric patients with congenital heart disease: single centre with 10 years of experience.
    Ergul Y; Sevinc Sengul F; Öztürk E; Kafalı HC; Ayyıldız P; Tanıdır IC; Akdeniz HS; Güneş M; Yıldız O; Haydin S; Güzeltaş A
    Cardiol Young; 2021 Jun; 31(6):940-948. PubMed ID: 33500007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy.
    Van de Veire NR; Marsan NA; Schuijf JD; Bleeker GB; Wijffels MC; van Erven L; Holman ER; De Sutter J; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2008 Apr; 101(7):1023-9. PubMed ID: 18359325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
    Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac resynchronization therapy: what? Who? When? How?
    Cuculich PS; Joseph S
    Am J Med; 2011 Sep; 124(9):813-5. PubMed ID: 21854888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure.
    Bleeker GB; Schalij MJ; Molhoek SG; Verwey HF; Holman ER; Boersma E; Steendijk P; Van Der Wall EE; Bax JJ
    J Cardiovasc Electrophysiol; 2004 May; 15(5):544-9. PubMed ID: 15149423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure.
    Valzania C; Gadler F; Eriksson MJ; Olsson A; Boriani G; Braunschweig F
    Eur J Heart Fail; 2007; 9(6-7):644-50. PubMed ID: 17347041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is mechanical dyssynchrony still a major determinant for responses after cardiac resynchronization therapy?
    Zhang Q; Yu CM
    J Cardiol; 2011 May; 57(3):239-48. PubMed ID: 21414757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiac resynchronization therapy (CRT) in patients with still mild heart failure].
    Herz; 2011 Oct; 36(7):643-4. PubMed ID: 22006035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.